WallStreetZenWallStreetZen

NYSEMKT: CLDI
Calidi Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Calidi Biotherapeutics earnings were -$25.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest CLDI earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$10.8M, up 89.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLDI reported annual earnings of -$23.8M, with -18.5% growth.

CLDI past earnings growth

How has CLDI's earnings growth performed historically?

Company
N/A
Industry
64.77%
Market
55.73%
CLDI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CLDI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

CLDI earnings history

Current Revenue
$0.0
Current Earnings
-$25.6M
Current Profit Margin
0%

CLDI Return on Equity

Current Company
-597.3%
Current Industry
-21.3%
Current Market
32%
CLDI's Return on Equity (-597.3%)... subscribe to Premium to read more.
High Return on Equity Performance

CLDI undefined

Current Company
-194.7%
Current Industry
-8.8%
CLDI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CLDI announces earnings.

CLDI undefined

Current Company
-221.67%
Current Industry
-3.4%
CLDI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLDI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CLDI-$17.97M-$25.62M-99.82%$0.54
AEON$78.00k-$3.00k-35.85%$4.03
PHGE-$8.15M-$13.40MN/A-$1.64
EVGN-$9.39M-$14.25MN/A-$2.04
BIVI-$18.10M-$18.57MN/A-$8.50
View Top Biotech Stocks

Calidi Biotherapeutics Earnings Reports & History FAQ

What were Calidi Biotherapeutics's earnings last quarter?

Calidi Biotherapeutics (NYSEMKT: CLDI) reported Q3 2025 earnings per share (EPS) of -$2.21, up 71.48% year over year. Total CLDI earnings for the quarter were -$10.82 million. In the same quarter last year, Calidi Biotherapeutics's earnings per share (EPS) was -$7.75.

If you're new to stock investing, here's how to buy Calidi Biotherapeutics stock.

Is Calidi Biotherapeutics profitable or losing money?

As of the last Calidi Biotherapeutics earnings report, Calidi Biotherapeutics is currently losing money. Calidi Biotherapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$19.95 million, a 24.08% decrease year over year.

What was CLDI's earnings growth in the past year?

As of Calidi Biotherapeutics's earnings date in Q4 2025, Calidi Biotherapeutics's earnings has grown year over year. CLDI earnings in the past year totalled -$25.62 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.